Yesterday, global leaders, policy makers, industry professionals and academics called on countries around the world to do more to help the 350 million people suffering from depression.  In particular they stressed the need for collaboration, urging healthcare systems, businesses and the general public to work together to fight depression.  The Global Crisis of Depression forum - organized by The Economist Events and sponsored by H. Lundbeck A/S - highlighted the global burden of depression, which is now the leading cause of disability worldwide.

On November 25, policymakers, healthcare providers, researchers, employers and patient groups will gather in London to consider national strategies to tackle what has become a leading cause of illness globally. Depression is a brain disease that severely impacts patients’ lives. Roughly half of patients fail to respond to initial anti-depressant therapy for reasons that include lack of efficacy, poor tolerability or residual symptoms such as cognitive dysfunction. No one understands this better than Lundbeck, the leading research-based pharmaceutical company dedicated to diseases of the brain, which is why CEO Ulf Wiinberg will join the panel discussion about treatment options in the 21st Century that day in London. Also sharing their views will be health ministers from the UK and Denmark, and experts from Sweden, Canada, Germany, the UK and the European Brain Council. 

Subscribe to RSS - mental health